Evidence map›Paper›PMID 34726179›Full record

ArticleActa crystallographica. Section F, Structural biology communications2021

Crystal structure of the [2Fe-2S] protein I (Shethna protein I) from Azotobacter vinelandii.

Burak V Kabasakal, Charles A R Cotton, James W Murray

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Burak V KabasakalDepartment of Life Sciences, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.ORCID 0000-0003-3001-9282
Charles A R CottonDepartment of Life Sciences, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.ORCID 0000-0002-5322-5292
James W MurrayDepartment of Life Sciences, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.ORCID 0000-0002-8897-0161
Imperial College London · GBAnkara University · TR

Funding

Biotechnology and Biological Sciences Research Council BB/F017324/1Biotechnology and Biological Sciences Research Council BB/L011468/1Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 118C225Wellcome Trust
6 · The paper itself

Abstract

Azotobacter vinelandii is a model diazotroph and is the source of most nitrogenase material for structural and biochemical work. Azotobacter can grow in above-atmospheric levels of oxygen, despite the sensitivity of nitrogenase activity to oxygen. Azotobacter has many iron-sulfur proteins in its genome, which were identified as far back as the 1960s and probably play roles in the complex redox chemistry that Azotobacter must maintain when fixing nitrogen. Here, the 2.1 Å resolution crystal structure of the [2Fe-2S] protein I (Shethna protein I) from A. vinelandii is presented, revealing a homodimer with the [2Fe-2S] cluster coordinated by the surrounding conserved cysteine residues. It is similar to the structure of the thioredoxin-like [2Fe-2S] protein from Aquifex aeolicus, including the positions of the [2Fe-2S] clusters and conserved cysteine residues. The structure of Shethna protein I will provide information for understanding its function in relation to nitrogen fixation and its evolutionary relationships to other ferredoxins.

Indexed as

Azotobacter vinelandiiIron-Sulfur ProteinsCrystallography, X-RayFerredoxinsNitrogenaseFerredoxinsIron-Sulfur ProteinsNitrogenaseAzotobacter vinelandiiiron–sulfur proteinsShethna protein I

Identifiers

PMID34726179
PMCPMC8561814
OpenAlexW3207274437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.